Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 40.23
+1.95 (5.09%)
At close: Jun 23, 2026
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 5.33 billion as of June 23, 2026. Its market cap has increased by 14.46% in one year.
Market Cap
5.33B
Enterprise Value
3.68B
Revenue
453.39M
Ranking
n/a
PE Ratio
129.75
Stock Price
40.23
Market Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 5.33B, a decrease of -48.89%. That is a compound annual growth rate of -16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 5.33B | -4.41% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
| Sep 2, 2022 | 10.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Youcare Pharmaceutical Group | 5.86B |
| Suzhou Fengbei Biotech Stock | 5.77B |
| Wuhan Keqian Biology Co.,Ltd | 5.70B |
| Hangzhou Biotest Biotech | 5.59B |
| Jiangsu Aidea Pharmaceutical Group | 5.29B |
| Anhui Huaheng Biotechnology | 5.20B |
| Shanghai Serum Bio-Technology | 5.17B |
| Novogene | 5.06B |